Correlation Between CERo Therapeutics and Blue Line

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CERo Therapeutics and Blue Line at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CERo Therapeutics and Blue Line into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CERo Therapeutics Holdings and Blue Line Protection, you can compare the effects of market volatilities on CERo Therapeutics and Blue Line and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CERo Therapeutics with a short position of Blue Line. Check out your portfolio center. Please also check ongoing floating volatility patterns of CERo Therapeutics and Blue Line.

Diversification Opportunities for CERo Therapeutics and Blue Line

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between CERo and Blue is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding CERo Therapeutics Holdings and Blue Line Protection in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blue Line Protection and CERo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CERo Therapeutics Holdings are associated (or correlated) with Blue Line. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blue Line Protection has no effect on the direction of CERo Therapeutics i.e., CERo Therapeutics and Blue Line go up and down completely randomly.

Pair Corralation between CERo Therapeutics and Blue Line

Assuming the 90 days horizon CERo Therapeutics Holdings is expected to generate 1.21 times more return on investment than Blue Line. However, CERo Therapeutics is 1.21 times more volatile than Blue Line Protection. It trades about 0.07 of its potential returns per unit of risk. Blue Line Protection is currently generating about 0.08 per unit of risk. If you would invest  8.00  in CERo Therapeutics Holdings on September 24, 2024 and sell it today you would lose (7.10) from holding CERo Therapeutics Holdings or give up 88.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy72.29%
ValuesDaily Returns

CERo Therapeutics Holdings  vs.  Blue Line Protection

 Performance 
       Timeline  
CERo Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Blue Line Protection 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Blue Line Protection has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

CERo Therapeutics and Blue Line Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CERo Therapeutics and Blue Line

The main advantage of trading using opposite CERo Therapeutics and Blue Line positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CERo Therapeutics position performs unexpectedly, Blue Line can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blue Line will offset losses from the drop in Blue Line's long position.
The idea behind CERo Therapeutics Holdings and Blue Line Protection pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories